Inside this portfolio
Identified stock classes31
Matched (%)92.64%
| Largest reported stocks | Portfolio weight |
|---|---|
| Eli Lilly & Co | 18.46% |
| AbbVie Inc | 8.85% |
| Novartis AG | 6.89% |
| Johnson & Johnson | 5.59% |
| Alkermes PLC | 5.53% |
How to read these numbers
The day the fund recorded its holdings.
The share of the fund’s net assets that we could identify as common-stock classes.